Since the mid-1970s, prenatal screening has advanced to include the development of tests for 800 genetic abnormalities. Access to noninvasive tests in the first and second trimesters of pregnancy is now the standard of care. An article in the New England Journal of Medicine examines the testing of fetal DNA in the mother's blood.

Related Summaries